Changes from 1 July 2022 From 1 July 2022, the eligibility criteria to access continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) products through the NDSS will be expanded to include all people with type 1 diabetes. From this date, all people with type 1 diabetes will be able to apply for access to CGM and Flash GM products using the process relevant to them. Once approved, eligible people will be able to access subsidised CGM and Flash GM products through NDSS Access Points (usually a community pharmacy) for a co-payment equivalent to $32.50 per one month’s supply. There are no changes for people with diabetes who currently access fully subsidised CGM or Flash GM products through the NDSS. People with type 1 diabetes aged 21 years or older who hold valid concessional status will continue to receive fully subsidised CGM and Flash GM products, that is, no co-payment will be required. Newly eligible people with type 1 diabetes The process a person with type 1 diabetes aged 21 years or older will need to take to start accessing subsidised products will depend on whether they have used CGM or Flash GM technology before (either accessed through the NDSS or directly from a product supplier). For most people, there are a few steps they will need to take. The exact date they can start purchasing subsidised products will depend on the pathway relevant to them. People who currently meet the existing eligibility criteria and have access to fully subsidised CGM or Flash GM products through the NDSS The eligibility criteria for access to fully subsidised CGM and Flash GM products (i.e., no co-payment) through the NDSS have not changed for the existing categories: children and young people aged under 21 years with type 1 diabetes people with type 1 diabetes aged 21 years or older who have valid concessional status women with type 1 diabetes who are actively planning pregnancy, pregnant, or immediately post-pregnancy children and young people under 21 years with conditions very similar to type 1 diabetes who require insulin. If a person is currently eligible under an existing category, they will continue to be able to access fully subsidised products through the NDSS for as long as they meet the eligibility criteria for that particular existing category. No action is required. If applicable, they will need to maintain valid concessional status. Co-payment amounts The exact co-payment a person will pay for a box of sensors will depend on the type of CGM or Flash GM device they are using and lifespan of the sensor. However, co-payments for all CGM and Flash products are equivalent – that is a person won’t pay more or less based on the product they are using. The co-payment for a box of sensors will be shown in the NDSS Connect portal. Validating concessional status People with type 1 diabetes aged 21 years or older who have valid concessional status can access fully subsidised CGM and Flash GM products, that is, no co-payment will be required. Concessional status can be updated in the NDSS Connect portal at the time of purchase. How do I respond to people registered with the NDSS if they have questions? People with queries—such as how they can access, who is eligible, what products are available, or the difference between individual products—should be directed to the NDSS website (ndss.com.au) or the NDSS Helpline on 1800 637 700. How can I get more information? NDSS Access points can obtain further information by: visiting the NDSS website emailing [email protected] calling the NDSS Helpline on 1800 637 700. Information for people with diabetes: Eligibility expansion – Rollout commencing 1 July 2022
